Investment Highlights
Medical-grade cannabis
with award winning quality
Premium products and services
with health and wellness focus
Innovation-driven product development
guided by data and insights
Focused international growth
with Europe as primary target
Strong financial position
to act quickly on opportunities
Diverse team of professionals
with global experience in regulated industries
Featured Video
Q3 2021 Results Video
Chairman & CEO, Ray Laflamme discusses VIVO’s Q3 2021 results.